CD8A and neoplasm: Following antigen activation, CD8+ T cells unleash a plethora of effector molecules, including cytokines (e.g., IFN-γ and TNFα) and cytotoxic agents inducing cell death (e.g., granzymes and FasL), which are integral to the process of tumor rejection (22, 37–39).